KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$420000.0.

  • Opko Health's Change in Accured Expenses fell 10101.17% to -$420000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.3 million, marking a year-over-year decrease of 23728.64%. This contributed to the annual value of $48.7 million for FY2024, which is 98886.25% up from last year.
  • Per Opko Health's latest filing, its Change in Accured Expenses stood at -$420000.0 for Q3 2025, which was down 10101.17% from -$24.2 million recorded in Q2 2025.
  • Opko Health's 5-year Change in Accured Expenses high stood at $41.5 million for Q3 2024, and its period low was -$36.2 million during Q1 2022.
  • Over the past 5 years, Opko Health's median Change in Accured Expenses value was -$8.5 million (recorded in 2022), while the average stood at -$6.6 million.
  • As far as peak fluctuations go, Opko Health's Change in Accured Expenses skyrocketed by 72629.38% in 2024, and later crashed by 175262.66% in 2025.
  • Over the past 5 years, Opko Health's Change in Accured Expenses (Quarter) stood at $32.0 million in 2021, then tumbled by 126.53% to -$8.5 million in 2022, then plummeted by 83.68% to -$15.6 million in 2023, then surged by 123.96% to $3.7 million in 2024, then plummeted by 111.26% to -$420000.0 in 2025.
  • Its Change in Accured Expenses was -$420000.0 in Q3 2025, compared to -$24.2 million in Q2 2025 and -$19.4 million in Q1 2025.